Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02997163 |
Title | An Open-Label Pharmacokinetics and Safety Study of Talazoparib |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Pfizer |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Fort Wayne Medical Oncology and Hematology, Inc. | Fort Wayne | Indiana | 46804 | United States | Details | |
Fort Wayne Medical Oncology and Hematology, Inc. | Fort Wayne | Indiana | 46845 | United States | Details | |
Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
Karmanos Cancer Institute Weisberg Cancer Treatment Center | Farmington Hills | Michigan | 48334 | United States | Details | |
Robert Wood Johnson University Hospital | New Brunswick | New Jersey | 08901 | United States | Details | |
Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | United States | Details | |
The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Cross Cancer Institute | Edmonton | Alberta | T6G 1Z2 | Canada | Details | |
Juravinski Cancer Centre | Hamilton | Ontario | L8V 5C2 | Canada | Details | |
Jewish General Hospital | Montreal | Quebec | H3T 1E2 | Canada | Details |